The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wani, M. C., Taylor, H. L., Wall, M. E., Coggon, P., & McPhail, A. T. (1971) · Journal of the American Chemical Society · doi:10.1021/ja00738a045 · Cited by 4,073
The Concept of Synthetic Lethality in the Context of Anticancer Therapy
Kaelin, W. G. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1691 · Cited by 1,379
Synergistic drug combinations tend to improve therapeutically relevant selectivity
Lehár, J., Krueger, A. S., Avery, W., Heilbut, A. M., Johansen, L. M., Price, E. R., Rickles, R. J., Short III, G. F., Staunton, J. E., Jin, X., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1549 · Cited by 938
Barry, M. A., Behnke, C. A., & Eastman, A. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90733-2 · Cited by 867
THE IMPACT OF NATIONAL CANCER ACT
(1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.24.1797 · Cited by 796
Multicomponent therapeutics for networked systems
Keith, C. T., Borisy, A. A., & Stockwell, B. R. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1609 · Cited by 769
Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer
Holmes, F. A., Walters, R. S., Theriault, R. L., Buzdar, A. U., Frye, D. K., Hortobagyi, G. N., Forman, A. D., Newton, L. K., & Raber, M. N. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.24.1797-a · Cited by 746
Chen, A. M., Zhang, M., Wei, D., Stueber, D., Taratula, O., Minko, T., & He, H. (2009) · Small · doi:10.1002/smll.200900621 · Cited by 671
Wang, Y., Gao, S., Ye, W.-H., Yoon, H. S., & Yang, Y.-Y. (2006) · Nature Materials · doi:10.1038/nmat1737 · Cited by 658
Okushima, S., Nisisako, T., Torii, T., & Higuchi, T. (2004) · Langmuir · doi:10.1021/la0480336 · Cited by 656
Stealth Me. PEG‐PLA Nanoparticles Avoid Uptake by the Mononuclear Phagocytes System
Bazile, D., Prud'homme, C., Bassoullet, M., Marlard, M., Spenlehauer, G., & Veillard, M. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840420 · Cited by 635
Ahmed, F., Pakunlu, R. I., Brannan, A., Bates, F., Minko, T., & Discher, D. E. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.07.012 · Cited by 548
Co-Delivery of siRNA and An Anticancer Drug for Treatment of Multidrug-Resistant Cancer
Saad, M., Garbuzenko, O. B., & Minko, T. (2008) · Nanomedicine · doi:10.2217/17435889.3.6.761 · Cited by 367
Qi, H., Hu, P., Xu, J., & Wang, A. (2006) · Biomacromolecules · doi:10.1021/bm060264z · Cited by 323
Nanoscale double emulsions stabilized by single-component block copolypeptides
Hanson, J. A., Chang, C. B., Graves, S. M., Li, Z., Mason, T. G., & Deming, T. J. (2008) · Nature · doi:10.1038/nature07197 · Cited by 290
Taxol sensitizes human astrocytoma cells to radiation.
Tishler, R. B., Geard, C. R., Hall, E. J., & Schiff, P. B. (1992) · PubMed · Cited by 265
Improving Penetration in Tumors With Nanoassemblies of Phospholipids and Doxorubicin
Tang, N., Du, G., Wang, N., Liu, C., Hang, H., & Liang, W. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm027 · Cited by 239
Lysosomal destabilization in p53-induced apoptosis
Yuan, X.-M., Li, W., Dalen, H., Lotem, J., Kama, R., Sachs, L., & Brunk, U. T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092135599 · Cited by 226
PLGA/polymeric liposome for targeted drug and gene co-delivery
Wang, H., Zhao, P., Su, W., Wang, S., Liao, Z., Niu, R., & Chang, J. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.07.082 · Cited by 209
Self-citationTanaka, T., Shiramoto, S., Miyashita, M., Fujishima, Y., & Kaneo, Y. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.09.050 · Cited by 206
Wiradharma, N., Tong, Y. W., & Yang, Y.-Y. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.03.006 · Cited by 204
Han, L., Huang, R., Li, J., Liu, S., Huang, S., & Jiang, C. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.09.070 · Cited by 190
Wang, J., Mongayt, D., & Torchilin, V. P. (2005) · Journal of Drug Targeting · doi:10.1080/10611860400011935 · Cited by 183
Huang, Y., Johnson, K. R., Norris, J. S., & Fan, W. (2000) · PubMed · Cited by 163
Galactosylated fluorescent labeled micelles as a liver targeting drug carrier
Wu, D.-Q., Lu, B., Chang, C., Chen, C.-S., Wang, T., Zhang, Y.-Y., Cheng, S.-X., Jiang, X.-J., Zhang, X.-Z., & Zhuo, R.-X. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.11.027 · Cited by 158
The co-delivery of paclitaxel and Herceptin using cationic micellar nanoparticles
Lee, A. L. Z., Wang, Y., Cheng, H. Y., Pervaiz, S., & Yang, Y. Y. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.10.062 · Cited by 157
Fan, L., Li, F., Zhang, H., Wang, Y., Cheng, C., Li, X., Gu, C., Yang, Q., Wu, H., & Zhang, S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.03.066 · Cited by 155
Liu, Y., Bhalla, K. N., Hill, C. K., & Prlest, D. G. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90164-3 · Cited by 116
From large networks to small molecules
Sharom, J. R., Bellows, D. S., & Tyers, M. (2003) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2003.12.007 · Cited by 103
PEGylated polycyanoacrylate nanoparticles as tumor necrosis factor-α carriers
Li, Y., Pei, Y., Zhou, Z.-H., Zhang, X., Gu, Z.-H., Ding, J., Zhou, J.-J., & Gao, X.-J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00235-8 · Cited by 76
Co-delivery of doxorubicin and plasmid by a novel FGFR-mediated cationic liposome
Xiao, W., Chen, X., Li, Y., Mao, Y.-Q., Wei, Y., & Chen, L. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.04.018 · Cited by 60
Gao, Y., Chen, L., Gu, W., Xi, Y., Lin, L., & Li, Y. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800072e · Cited by 56
Protein-loaded PLGA–PEO blend nanoparticles: encapsulation, release and degradation characteristics
Santander-Ortega, M. J., Csaba, N., González, L., Bastos‐González, D., Ortega-Vinuesa, J. L., & Alonso, M. J. (2009) · Colloid & Polymer Science · doi:10.1007/s00396-009-2131-z · Cited by 55
Amphiphilic hyper-branched co-polymer nanoparticles for the controlled delivery of anti-tumor agents
Miao, Q., Xu, D., Wang, Z., Xu, L., Wang, T., Wu, Y. F., Lovejoy, D. B., Kalinowski, D. S., Richardson, D. R., Nie, G., et al. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.06.012 · Cited by 47
Self-citationMechanism of doxorubicin-induced cell death and expression profile analysis
Lee, S., Bæk, M., Kim, H., Ha, J., & Jeoung, D. (2002) · Biotechnology Letters · doi:10.1023/a:1016174800956 · Cited by 31
Cited by
Ulbrich, K., Holá, K., Šubr, V., Bakandritsos, A., Tuček, J., & Zbořil, R. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00589 · Cited by 1,730
Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors
Din, F. U., Aman, W., Ullah, I., Qureshi, O. S., Mustapha, O., Shafique, S., & Zeb, A. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s146315 · Cited by 1,577
Physicochemical Properties Determine Nanomaterial Cellular Uptake, Transport, and Fate
Zhu, M., Nie, G., Meng, H., Xia, T., Nel, A., & Zhao, Y. (2013) · Accounts of Chemical Research · doi:10.1021/ar300031y · Cited by 803
Self-citationPolymeric nanoparticles for targeted drug delivery system for cancer therapy
Masood, F. (2016) · Materials Science and Engineering: C · doi:10.1016/j.msec.2015.11.067 · Cited by 702
Enzyme-responsive nanomaterials for controlled drug delivery
Hu, Q., Katti, P. S., & Gu, Z. (2014) · Nanoscale · doi:10.1039/c4nr04249b · Cited by 668
Metadata
- Authors
- Wang, H., Zhao, Y., Wu, Y., Hu, Y.-L., Nan, K., Nie, G., & Chen, H.
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2011-11
- Volume
- 32
- Issue
- 32
- Pages
- 8281-8290
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W2153409108
- Cited by
- 603
- References
- 35
- FWCI
- 14.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.